Antigen-binding fusion proteins
US5767260A · kind A · utility
55Cited by
9References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 1995 |
| Grant date | Jun 16, 1998 |
| Priority date | — |
| Expiry date | Aug 16, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions of, genetic constructions coding for, and methods for producing single-chain and multivalent immunoeffector antigen-binding fusion proteins are provided by the invention. Antigen-binding fusion proteins having phospholipase A activating protein and/or tumor necrosis factor fragments are also provided by the invention. Genetic sequences coding for single-chain and multivalent immunoeffector antigen-binding fusion proteins are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.